First Wave BioPharma $40 PT Upside potential

Before the close of the year the Bio Pharma Sector started running wild. It doesn't surprise me why i'm drawn to this company with all the catalysts coming out. Recently with a PT 40 From Roth MKM.

The more you read about the news that comes from this company between CEO investor relations, Merger Deal with Immunogen and entering their phase 3 trial there is so much Upside potential.

Although short term there's a lot of turbulence in the 5.00-5.38 range if it can break and hold strong this stock can get there pretty quick.

Currently holding a Long position.

Trade Responsible,
#TradeTheWave 🏄🏽‍♂️🌊


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.